Miss Elaine McCartney

  • Lead Biostatistician (Clinical Research Gartnavel)

email: Elaine.McCartney@glasgow.ac.uk

Cancer Research UK, Clinical Trials Unit Level 0, Beatson Cancer Centre, 1053 Great Western Road G12 0YN

Import to contacts

ORCID iDhttps://orcid.org/0000-0002-0260-4161

Publications

List by: Type | Date

Jump to: 2025 | 2024 | 2023 | 2021 | 2019 | 2017 | 2016 | 2015 | 2013 | 2012
Number of items: 14.

2025

Tate, M. et al. (2025) Clinical effectiveness, safety and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomised, phase III trial. Antimicrobial Agents and Chemotherapy, (doi: 10.1128/aac.00054-25) (PMID:40552814) (Early Online Publication)

2024

Heggie, Robert, Jaiswal, Nishant ORCID logoORCID: https://orcid.org/0000-0001-5511-4572, McCartney, Elaine ORCID logoORCID: https://orcid.org/0000-0002-0260-4161, Moss, Jon, Menne, Tobias, Jones, Brian, Boyd, Kathleen ORCID logoORCID: https://orcid.org/0000-0002-9764-0113, Soulis, Eileen, Hawkins, Neil ORCID logoORCID: https://orcid.org/0000-0003-3199-221X and Wu, Olivia ORCID logoORCID: https://orcid.org/0000-0002-0570-6016 (2024) Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation. Value in Health, 27(1), pp. 7-14. (doi: 10.1016/j.jval.2023.09.2996) (PMID:37844662)

2023

Rushworth, L. K. et al. (2023) Phase II proof of concept study of atorvastatin in castration resistant prostate cancer. BJU International, 131(2), pp. 236-243. (doi: 10.1111/bju.15851) (PMID:35844167) (PMCID:PMC10087532)

2021

Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)

Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)

2019

Zhou, C. et al. (2019) Dynamics of circulating vascular endothelial growth factor-A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients. British Journal of Clinical Pharmacology, 85(8), pp. 1781-1789. (doi: 10.1111/bcp.13965) (PMID:30980733) (PMCID:PMC6624436)

Hatton, M. Q.F. et al. (2019) Accelerated, dose escalated, sequential chemoradiotherapy in non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study. BMJ Open, 9(1), e019903. (doi: 10.1136/bmjopen-2017-019903) (PMID:30700475) (PMCID:PMC6352760)

2017

Lawless, C.A. et al. (2017) ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). UNSPECIFIED S80-S81. (doi: 10.1016/S0169-5002(17)30221-0)

2016

Wu, Olivia ORCID logoORCID: https://orcid.org/0000-0002-0570-6016, Boyd, Kathleen ORCID logoORCID: https://orcid.org/0000-0002-9764-0113, Paul, Jim ORCID logoORCID: https://orcid.org/0000-0001-7367-5816, McCartney, Elaine ORCID logoORCID: https://orcid.org/0000-0002-0260-4161, Ritchie, Moira, Mellon, D., Kelly, Linda, Dixon-Hughes, Judith and Moss, Jonathan (2016) Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation. British Journal of Cancer, 114(9), pp. 979-985. (doi: 10.1038/bjc.2016.76) (PMID:27092784)

Marshall-Mckenna, R. ORCID logoORCID: https://orcid.org/0000-0001-8698-6613, Morrison, A., Stirling, L., Hutchison, C., Rice, A.M., Hewitt, C., Paul, L., Rodger, M., MacPherson, I. ORCID logoORCID: https://orcid.org/0000-0003-4295-8885 and McCartney, E. ORCID logoORCID: https://orcid.org/0000-0002-0260-4161 (2016) A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancer. Supportive Care in Cancer, 24(4), pp. 1821-1829. (doi: 10.1007/s00520-015-2967-3) (PMID:26446702)

2015

Symonds, R. P. et al. (2015) Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Oncology, 16(15), pp. 1515-1524. (doi: 10.1016/S1470-2045(15)00220-X) (PMID:26474517) (PMCID:PMC4705431)

2013

Ahmad, I., Kalna, G., Ismail, M., Birrell, F., Asterling, S., McCartney, E. ORCID logoORCID: https://orcid.org/0000-0002-0260-4161, Greene, D., Davies, J. and Leung, H.Y. ORCID logoORCID: https://orcid.org/0000-0002-3933-3975 (2013) Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer. PLoS ONE, 8(8), e69243. (doi: 10.1371/journal.pone.0069243) (PMID:23950886) (PMCID:PMC3739755)

White, J. D. et al. (2013) RESTART: Rehabilitation Evaluation in Survivors of Testicular Cancer after Radical Treatment-Pilot study effect on HADS-anxiety subscore. Journal of Clinical Oncology, 31,

2012

Carruthers, R. ORCID logoORCID: https://orcid.org/0000-0003-1077-6120, Tho, L.M., Brown, J., Kakumanu, S., McCartney, E. ORCID logoORCID: https://orcid.org/0000-0002-0260-4161 and McDonald, A.C. (2012) Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Disease, 14(10), e701-e707. (doi: 10.1111/j.1463-1318.2012.03147.x)

This list was generated on Wed Jul 9 07:22:28 2025 BST.
Jump to: Articles | Conference or Workshop Item
Number of items: 14.

Articles

Tate, M. et al. (2025) Clinical effectiveness, safety and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomised, phase III trial. Antimicrobial Agents and Chemotherapy, (doi: 10.1128/aac.00054-25) (PMID:40552814) (Early Online Publication)

Heggie, Robert, Jaiswal, Nishant ORCID logoORCID: https://orcid.org/0000-0001-5511-4572, McCartney, Elaine ORCID logoORCID: https://orcid.org/0000-0002-0260-4161, Moss, Jon, Menne, Tobias, Jones, Brian, Boyd, Kathleen ORCID logoORCID: https://orcid.org/0000-0002-9764-0113, Soulis, Eileen, Hawkins, Neil ORCID logoORCID: https://orcid.org/0000-0003-3199-221X and Wu, Olivia ORCID logoORCID: https://orcid.org/0000-0002-0570-6016 (2024) Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation. Value in Health, 27(1), pp. 7-14. (doi: 10.1016/j.jval.2023.09.2996) (PMID:37844662)

Rushworth, L. K. et al. (2023) Phase II proof of concept study of atorvastatin in castration resistant prostate cancer. BJU International, 131(2), pp. 236-243. (doi: 10.1111/bju.15851) (PMID:35844167) (PMCID:PMC10087532)

Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)

Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)

Zhou, C. et al. (2019) Dynamics of circulating vascular endothelial growth factor-A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients. British Journal of Clinical Pharmacology, 85(8), pp. 1781-1789. (doi: 10.1111/bcp.13965) (PMID:30980733) (PMCID:PMC6624436)

Hatton, M. Q.F. et al. (2019) Accelerated, dose escalated, sequential chemoradiotherapy in non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study. BMJ Open, 9(1), e019903. (doi: 10.1136/bmjopen-2017-019903) (PMID:30700475) (PMCID:PMC6352760)

Wu, Olivia ORCID logoORCID: https://orcid.org/0000-0002-0570-6016, Boyd, Kathleen ORCID logoORCID: https://orcid.org/0000-0002-9764-0113, Paul, Jim ORCID logoORCID: https://orcid.org/0000-0001-7367-5816, McCartney, Elaine ORCID logoORCID: https://orcid.org/0000-0002-0260-4161, Ritchie, Moira, Mellon, D., Kelly, Linda, Dixon-Hughes, Judith and Moss, Jonathan (2016) Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation. British Journal of Cancer, 114(9), pp. 979-985. (doi: 10.1038/bjc.2016.76) (PMID:27092784)

Marshall-Mckenna, R. ORCID logoORCID: https://orcid.org/0000-0001-8698-6613, Morrison, A., Stirling, L., Hutchison, C., Rice, A.M., Hewitt, C., Paul, L., Rodger, M., MacPherson, I. ORCID logoORCID: https://orcid.org/0000-0003-4295-8885 and McCartney, E. ORCID logoORCID: https://orcid.org/0000-0002-0260-4161 (2016) A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancer. Supportive Care in Cancer, 24(4), pp. 1821-1829. (doi: 10.1007/s00520-015-2967-3) (PMID:26446702)

Symonds, R. P. et al. (2015) Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Oncology, 16(15), pp. 1515-1524. (doi: 10.1016/S1470-2045(15)00220-X) (PMID:26474517) (PMCID:PMC4705431)

Ahmad, I., Kalna, G., Ismail, M., Birrell, F., Asterling, S., McCartney, E. ORCID logoORCID: https://orcid.org/0000-0002-0260-4161, Greene, D., Davies, J. and Leung, H.Y. ORCID logoORCID: https://orcid.org/0000-0002-3933-3975 (2013) Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer. PLoS ONE, 8(8), e69243. (doi: 10.1371/journal.pone.0069243) (PMID:23950886) (PMCID:PMC3739755)

White, J. D. et al. (2013) RESTART: Rehabilitation Evaluation in Survivors of Testicular Cancer after Radical Treatment-Pilot study effect on HADS-anxiety subscore. Journal of Clinical Oncology, 31,

Carruthers, R. ORCID logoORCID: https://orcid.org/0000-0003-1077-6120, Tho, L.M., Brown, J., Kakumanu, S., McCartney, E. ORCID logoORCID: https://orcid.org/0000-0002-0260-4161 and McDonald, A.C. (2012) Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Disease, 14(10), e701-e707. (doi: 10.1111/j.1463-1318.2012.03147.x)

Conference or Workshop Item

Lawless, C.A. et al. (2017) ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). UNSPECIFIED S80-S81. (doi: 10.1016/S0169-5002(17)30221-0)

This list was generated on Wed Jul 9 07:22:28 2025 BST.